The Pacer Global Cash Cows Dividend ETF (GCOW) tracks the Pacer Global Cash Cows Dividend Index, a rules-based benchmark that selects developed-market large-cap companies offering high dividend yields supported by high free cash flow yield, with holdings weighted by aggregate dividends paid. This "cash cows" approach favors mature, capital-light businesses that generate dependable cash rather than high-growth names, giving the fund a pronounced value tilt.
Sector exposure is heavily skewed toward consumer defensive (staples), healthcare, communication services, and energy, with smaller allocations to industrials, utilities, consumer cyclical, basic materials, and only a modest technology weighting. Top holdings have historically included Bristol-Myers Squibb (BMY), Medtronic (MDT), Comcast (CMCSA), Philip Morris International (PM), AT&T (T), Chevron (CVX), and Verizon Communications (VZ), alongside European names such as Unilever and Novartis. I also checked this using Tickeron’s AI Screener to see how the holdings compare across the industry.
Geographically, the portfolio is dominated by developed Europe, followed by North America and Asia, with limited emerging-market exposure. The fund carries a net expense ratio of 0.60% and distributes income quarterly. Because it is not currency hedged, foreign-exchange movements are a structural driver of both returns and volatility. This defensive, income-oriented positioning means the fund's future performance potential is closely tied to dividend sustainability, free cash flow durability, and the relative attractiveness of high-yield equities versus fixed income.
The broader macro environment is likely to be the dominant force shaping this ETF's trajectory. Lower interest rates and softer inflation generally improve the relative appeal of high-dividend, defensive equities, while an environment of elevated rates tends to keep investors anchored to fixed income. The fund's sizable consumer staples and healthcare weightings provide defensive ballast during economic slowdowns, yet its energy and communication-services exposure keeps it sensitive to commodity cycles and consumer spending trends.
Global equity market trends also matter. Should value and international stocks continue to lead, the fund's developed-markets, non-U.S. tilt would benefit. Conversely, a renewed technology-led growth rally could leave the portfolio lagging, given its minimal tech allocation. Currency movements are equally important: a weaker U.S. dollar typically enhances returns from the fund's European and Asian holdings, while dollar strength acts as a headwind. Bond market dynamics add another layer, as the fund's roughly 4% dividend yield becomes more compelling when sovereign yields fall. From what I see, monitoring these factors with tools like Tickeron’s AI Trend Prediction Engine helps clarify short-term biases.
Over a longer horizon, several structural themes are likely to influence the fund. Aging demographics in developed markets support steady demand for healthcare and pharmaceutical products, aligning with the portfolio's substantial healthcare exposure. The ongoing shift toward income generation among an aging investor base could sustain structural demand for high-dividend strategies. Meanwhile, the global transition toward cleaner energy introduces both opportunity and risk for traditional energy holdings, as cash flows remain tied to fossil-fuel prices even as companies diversify.
The fund's emphasis on free cash flow is a structural strength: companies that convert revenue into cash efficiently tend to maintain dividends through economic cycles. However, its minimal technology exposure means it may underparticipate in long-term digitalization and artificial-intelligence-driven growth. Interest-rate cycles will continue to shape the relative appeal of dividend equities versus bonds, and currency dynamics will remain a persistent influence given the fund's unhedged international footprint. These long-term drivers frame the fund's structural positioning without implying any specific return outcome. I’m watching this closely as rate paths evolve.
In my analysis of income-focused ETFs like GCOW, I turned to Tickeron’s AI Trend Prediction Engine to get a data-driven view on potential short-term trends. It helps flag bullish, bearish, or sideways biases across assets and provides historical context alongside alerts. This fits well alongside fundamental and macro reviews when evaluating developed-market dividend strategies.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GCOW declined for three days, in 167 of 236 cases, the price declined further within the following month. The odds of a continued downward trend are 71%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GCOW as a result. In 46 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.
The Moving Average Convergence Divergence Histogram (MACD) for GCOW turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 27 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
GCOW moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.
The RSI Indicator entered the oversold zone -- be on the watch for GCOW's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for GCOW crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where GCOW advanced for three days, in 280 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
GCOW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 304 of 358 cases where GCOW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows